1-(2-thiazolylazo)-2-naphthol has been researched along with Prostatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalgard, CL; Dobi, A; Kumar, V; LaRonde, NA; Malhotra, SV; McLeod, DG; Mohamed, AA; Petrovics, G; Ravindranath, L; Rosner, IL; Seraj, N; Sreenath, T; Srivastava, M; Srivastava, S; Strovel, J; Sukumar, G; Tan, SH; Xavier, CP | 1 |
1 other study(ies) available for 1-(2-thiazolylazo)-2-naphthol and Prostatic Neoplasms
Article | Year |
---|---|
Identification of a Small Molecule That Selectively Inhibits ERG-Positive Cancer Cell Growth.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azo Compounds; Benzamides; Cell Line, Tumor; Humans; Male; Mice; Mice, Nude; Nitriles; Oncogene Proteins, Fusion; Phenylthiohydantoin; Prostatic Neoplasms; Protein Serine-Threonine Kinases; RNA, Small Interfering; Small Molecule Libraries; Transcriptional Regulator ERG; Xenograft Model Antitumor Assays | 2018 |